144 related articles for article (PubMed ID: 38040517)
1. mRNA vaccines in the rheumatologist's future.
Kl W
Semin Arthritis Rheum; 2024 Feb; 64S():152325. PubMed ID: 38040517
[TBL] [Abstract][Full Text] [Related]
2. What rheumatologists need to know about mRNA vaccines: current status and future of mRNA vaccines in autoimmune inflammatory rheumatic diseases.
Park JK; Lee EB; Winthrop KL
Ann Rheum Dis; 2024 May; 83(6):687-695. PubMed ID: 38413167
[TBL] [Abstract][Full Text] [Related]
3. Development of mRNA vaccines against respiratory syncytial virus (RSV).
Qiu X; Xu S; Lu Y; Luo Z; Yan Y; Wang C; Ji J
Cytokine Growth Factor Rev; 2022 Dec; 68():37-53. PubMed ID: 36280532
[TBL] [Abstract][Full Text] [Related]
4. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2.
Plüß M; Mese K; Kowallick JT; Schuster A; Tampe D; Tampe B
Front Immunol; 2021; 12():784145. PubMed ID: 35116025
[TBL] [Abstract][Full Text] [Related]
6. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.
Shafiee A; Amini MJ; Arabzadeh Bahri R; Jafarabady K; Salehi SA; Hajishah H; Mozhgani SH
Eur J Med Res; 2023 Aug; 28(1):278. PubMed ID: 37559096
[TBL] [Abstract][Full Text] [Related]
7. mRNA vaccines against respiratory viruses.
Whitaker JA; Sahly HME; Healy CM
Curr Opin Infect Dis; 2023 Oct; 36(5):385-393. PubMed ID: 37462930
[TBL] [Abstract][Full Text] [Related]
8. mRNA vaccines: The future of prevention of viral infections?
Rzymski P; Szuster-Ciesielska A; Dzieciątkowski T; Gwenzi W; Fal A
J Med Virol; 2023 Feb; 95(2):e28572. PubMed ID: 36762592
[TBL] [Abstract][Full Text] [Related]
9. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.
Kotomina T; Isakova-Sivak I; Matyushenko V; Kim KH; Lee Y; Jung YJ; Kang SM; Rudenko L
Antiviral Res; 2019 Aug; 168():9-17. PubMed ID: 31075351
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
Mourgues C; Henquell C; Tatar Z; Pereira B; Nourisson C; Tournadre A; Soubrier M; Couderc M
Joint Bone Spine; 2016 Jul; 83(4):412-5. PubMed ID: 26725744
[TBL] [Abstract][Full Text] [Related]
11. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
12. The future of respiratory syncytial virus vaccine development.
Polack FP; Karron RA
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S65-73. PubMed ID: 14730272
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
14. Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.
Xue M; Wang R; Harder O; Chen P; Lu M; Cai H; Li A; Liang X; Jennings R; La Perle K; Niewiesk S; Peeples ME; Li J
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999025
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus: the hematologic and oncologic consequences of virus-host interaction.
Giller RH; Grose C
Crit Rev Oncol Hematol; 1989; 9(2):149-95. PubMed ID: 2545365
[TBL] [Abstract][Full Text] [Related]
16. Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods.
Smith TRF; Schultheis K; Broderick KE
Hum Vaccin Immunother; 2017 Nov; 13(11):2626-2629. PubMed ID: 28881156
[TBL] [Abstract][Full Text] [Related]
17. Development and qualification of cell-based relative potency assay for a human respiratory syncytial virus (RSV) mRNA vaccine.
Li HH; Xu J; He L; Denny LI; Rustandi RR; Dornadula G; Fiorito B; Zhang ZQ
J Pharm Biomed Anal; 2023 Sep; 234():115523. PubMed ID: 37336039
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus, Epstein-Barr virus and varicella zoster virus infection in the first two years of life: a cohort study in Bradford, UK.
Pembrey L; Waiblinger D; Griffiths P; Patel M; Azad R; Wright J
BMC Infect Dis; 2017 Mar; 17(1):220. PubMed ID: 28320319
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development.
Maple PAC
Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 31968673
[TBL] [Abstract][Full Text] [Related]
20. Vaccines against human respiratory syncytial virus in clinical trials, where are we now?
Rossey I; Saelens X
Expert Rev Vaccines; 2019 Oct; 18(10):1053-1067. PubMed ID: 31587585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
